Bayer subsidiary doses first patient with Parkinson’s disease cell therapy

Bayer subsidiary doses first patient with Parkinson’s disease cell therapy
German pharma company announces progress in its 'two-pronged' cell and gene therapy approach to Parkinson's disease ... read more
Source: Bing NewsPublished on 2021-06-09